Research funding

Ongoing

• ERA4Health NANOTECMED project "Lipid replacement therapy for patients with congenital ichthyosis using topical acylceramide nanostructured delivery systems (LIPARCI II)

• 2025-2027 Czech Science Foundation project "Understanding the mechanisms of epidermal lipid barrier formation, damage and repair: implications for skin diseases" (25-17203S with UCT Prague)

• 2024-2027 AZV project "Skin Barrier Lipidomics as a Noninvasive Method for Predicting Late Adverse Events in Childhood Cancer Survivors" (NW24-08-00289)

• 2024-2026 Czech Science Foundation project "Corneocyte lipid envelope: lipid-protein binding mechanisms and barrier rescue in ichthyosis models" (24-10736S)

• 2024-2028 MEYS project "New Technologies for Translational Research in Pharmaceutical Sciences" (NETPHARM, CZ.02.01.01/00/22_008/0004607)

• 2025-2027: Charles University project 384725 “Study of the effects of micro and nanoplastics on the nanostructure and permeability of skin lipid barrier models” (Ajit Pratihast)

• 2025-2027: Charles University project 432825 “Restoring the damaged skin barrier: topical administration of barrier lipids and anti-inflammatory drugs” (Filipa Pires de Castro)

• 2026-2029: Charles University project RTNS25-032 “Glucocorticoid-Mediated Remodeling of Skin Lipid Microstructure and Barrier Integrity” (Anna Paraskevopoulou)

Past

• 2022-2025: ERA-NET Cofund EuroNanoMed3/TAČR “Pre-clinical development of an acylceramide nanostructured delivery system to rescue the skin barrier in patients with ichthyosis (LIPARCI)"

• 2022-2025: Czech Science Foundation-German Science Foundation Lead Agency project 22-20839K (with Huster Lab, University of Lepzig) "Novel Insights into the Nanostructure of the Skin Lipid Barrier by Biophysical Methods"

• 2022-2024: Charles University project 348222"Lipid-covered gold nanoparticles as a model of human corneocyte lipid envelope" (Sorina Hirbod)

• 2021-2023: Charles University project 262821 "Synthesis and modification of surfaces as templates for skin barrier lipid assembly" (Panagiota Velissari)

• 2019-2022: Operation Programme Research, Development and Education CZ.02.1.01/0.0/0.0/16_019/0000841Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods – New Challenges (EFSA–CDN)

• 2019-2022: Operation Programme Research, Development and Education CZ.02.1.01/0.0/0.0/18_069/0010046 Pre-application research into innovative medicines and medical technologies (InoMed)

• 2019-2021: Czech Science Foundation-German Science Foundation joint project 19-09135J (with D. Huster, University of Leipzig): Ultralong chain ceramides in membrane models of healthy and diseased skin barrier

• 2019-2021: Czech Science Foundation project 19-09600S (with J. Zbytovská, University of Chemistry and Technology Prague) Integrated design methodology of nanoformulation processes for (trans )dermal delivery of actives

• 2021-2022: Charles University project 274221 "Advanced topical delivery systems combining dendrimers and liposomes​" (Eleni Panoutsopoulou)

• 2020-2022: Charles University project 1156120 "Study of the effects of (patho)physiological conditions on the nanostructure and permeability of skin lipid barrier models" (Irene Sagrafena)

• 2016-2018: Czech Science Foundation and German Science Foundation joint project 16-25687J "Interdependencies between Inflammatory Processes and Barrier Lipids in Diseased Skin" (with Prof. Sarah Hedrich, Freie Universitaet Berlin)

• 2019-2021: Charles University project 1194119 "Syntéza a studium vlivu ω hydroxylovaných ceramidů, volných i vázaných v korneocytální lipidové obálce, na bariérovou funkci kůže" (Veronika Sommerová)

• 2017-2019: Charles University project 184217 "Modulátory bariérové funkce kůže" (Anna Nováčková)